Ticker brief
EVAX
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
11
authors 14d
7
crowd 14d
+0.5σ
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-08-19 → 2026-08-20 · now +0.38 (−1 bearish … +1 bullish)
Who spoke7
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @abc51648039 | C | -1.29 | 4 | +0.35 |
| @AlertsAndNews | C | -1.90 | 2 | +0.23 |
| @Analytica_X | B | +1.03 | 1 | +0.50 |
| @TrendSpider | C | -1.01 | 1 | +0.30 |
| @KampnerSam | A | +0.20 | 1 | +0.15 |
| @SeegerErik | C | -0.36 | 1 | +0.35 |
| @JensKlattFX | B | +0.50 | 1 | +0.50 |
Recent signals11of 11 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-08-20 | @abc51648039 | +0.30 | Flags a potential EVAX reversal contingent on holding above VWAP. | · | tweet ↗ |
| 2026-08-20 | @JensKlattFX | +0.50 | Maps public cancer-vaccine peers, sympathy moves, clinical prospects, and M&A potential | · | tweet ↗ |
| 2026-08-20 | @abc51648039 | +0.35 | Lists bullish trigger, resistance and support levels for EVAX without entry intent. | · | tweet ↗ |
| 2026-08-20 | @SeegerErik | +0.35 | Reports EVAX premarket at $4.073, up 29.31%. | · | tweet ↗ |
| 2026-08-20 | @abc51648039 | +0.45 | Watch-list setup gives a bullish threshold and potential upside levels. | · | tweet ↗ |
| 2026-08-20 | @abc51648039 | +0.30 | Daily watch list highlights strong movement and asks for breakout confirmation rather than chasing. | · | tweet ↗ |
| 2026-08-19 | @AlertsAndNews | +0.20 | Lists updated after-hours gappers without entry intent. | · | tweet ↗ |
| 2026-08-19 | @AlertsAndNews | +0.25 | Notes EVAX and VRAX moving as sympathy plays to MRNA. | · | tweet ↗ |
| 2026-08-19 | @KampnerSam | +0.15 | Reports positive Phase 3 cancer-vaccine results and maps related public companies. | · | tweet ↗ |
| 2026-08-19 | @TrendSpider | +0.30 | AI scan identifies public companies advancing mRNA technology after a cancer-vaccine breakthrough. | · | tweet ↗ |
| 2026-08-19 | @Analytica_X | +0.50 | Reports positive Phase 3 cancer-vaccine results and bullish readthroughs for personalized vaccine platforms | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.